Large effect size in composite kidney outcomes than in majors cardiovascular events of SGLT2 inhibitors compared with GLP-1 RAs: a pooled analysis of type 2 diabetes trials
Diallo A, Carlos-Bolumbu M, Renard E, Galtier F
Diabetes Obes Metab. Pub. online 3 Sep 2022.
Leggi